Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
754 studies found for:    Epoetin alfa OR Epogen, Procrit[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
1 Completed Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Conditions: Anemia;   Chronic Kidney Disease (CKD)
Interventions: Drug: HX575 epoetin alfa;   Drug: US-licensed epoetin alfa
2 Completed
Has Results
An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
Condition: Anemia
Interventions: Drug: Epoetin alfa 3 times weekly /once weekly;   Drug: Epoetin alfa once weekly;   Drug: Epoetin alfa once every two weeks
3 Completed HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)
Condition: Chronic Kidney Disease
Intervention: Drug: HX575 epoetin alfa (Sandoz)
4 Completed Comparison Among Erythropoietin Stimulating Agents
Condition: Anemia of End Stage Renal Disease
Interventions: Drug: Epoetin alpha or beta (Epoetin group);   Drug: Darbepoetin alfa;   Drug: Methoxy polyethylene glycol-epoetin beta
5 Withdrawn Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
Condition: Anemia
Intervention: Drug: Epoetin Alfa plus Iron
6 Completed Efficacy Study of Epoetin Alfa in Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: Epoetin alfa;   Drug: Placebo
7 Terminated
Has Results
Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa
Condition: Subarachnoid Hemorrhage
Interventions: Drug: Epoetin alfa;   Drug: Saline
8 Completed
Has Results
A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
Conditions: Renal Failure , Chronic;   Anemia
Interventions: Drug: Epoetin Alfa;   Other: Standard of care
9 Terminated
Has Results
A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy
Conditions: Neoplasms;   Anemia;   Cancer
Interventions: Drug: epoetin alfa;   Drug: darbepoetin alfa
10 Terminated
Has Results
Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis
Condition: Anemia
Interventions: Drug: Peginesatide;   Drug: Epoetin alfa
11 Terminated
Has Results
The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery
Condition: Hemostasis, Surgical
Interventions: Drug: Epoetin alfa;   Drug: Standard of Care
12 Completed Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: Epoetin alfa
13 Completed Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis
Condition: Nephrology
Interventions: Drug: Epoetin alfa RB;   Drug: Epoetin alfa DT
14 Withdrawn Epoetin Alfa for HIV-Associated Neuropathy Trial
Conditions: HIV Infections;   Neuropathy
Intervention: Drug: epoetin alfa
15 Completed
Has Results
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome;   Leukemia
Intervention: Drug: Procrit
16 Completed A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
Condition: Pure Red-cell Aplasia
Intervention: Drug: No intervention
17 Not yet recruiting To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers
Condition: Healthy
Interventions: Drug: EPORON;   Drug: EPREX
18 Completed
Has Results
PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients
Conditions: Anemia;   Renal Diseases
Intervention: Drug: epoetin alfa
19 Completed
Has Results
Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy
Condition: Leukemia
Intervention: Drug: Procrit (epoetin alfa)
20 Recruiting Optimized Erythropoietin (EPO) Treatment
Condition: Neonatal Anemia
Interventions: Drug: Epoetin Alpha;   Drug: Biotinylated Red Blood Cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years